AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (7)

Latest Articles

About This Stock More About This Stock
CMRX Brincidofovir Selected For Use In Ebola Clinical Trial; AZN And ISIS To Co-Develop Targeted Oligonucleotide Delivery Methods
Article By: BioMedReports
Friday, November 14, 2014 3:21 AM EDT
CMRX announced its investigational broad-spectrum antiviral brincidofovir has been selected as one of two investigational agents to be evaluated in a clinical study with ebola. (ISIS) and (AZN) announced a strategic alliance to develop novel delivery methods for antisense oligonucleotides.
In this article: AZN, ISIS, CMRX
Read
AZN And PCYC Enter Clinical Trial Collaboration To Evaluate IMBRUVICA
Article By: BioMedReports
Wednesday, November 5, 2014 3:14 AM EDT
AstraZeneca and Pharmacyclics will collaborate on a non-exclusive basis and multiple studies may be considered and conducted. The studies will be led by AstraZeneca.
In this article: AZN, COV, PCYC
Read
E Large Cap Best And Worst Report
Article By: E.B. Capital Markets
Tuesday, November 4, 2014 9:18 AM EDT
The average large cap score is 69.53, above the four week moving average score of 62.40. The average large cap stock is trading -10.26% below its 52 week high, 2.58% above its 200 dma, has 3.91 days to cover held short, and is expected to see EPS growth of 11.43% next year.
In this article: AU, AVP, AZN, DIS, ED, GG, HCN, OCR, SBSA, FB, SPX, ABBV
Read
Movers: JNJ, PRGO, AZN, ACHC, CRL
Article By: BioMedReports
Thursday, October 30, 2014 5:34 PM EDT
U.S. stocks extended gains in afternoon trading, as a strong earnings report from Visa Inc. spurred a sharp advance in the Dow industrials.
In this article: AZN, CRL, JNJ, ACHC, PRGO
Read
Pfizer Beats Earnings, But Lacks Year-Over-Year EPS Growth
Article By: Zacks Investment Research
Tuesday, October 28, 2014 9:43 AM EDT
PFE posted stronger than expected quarterly results, helped by growing sales of its cancer drugs and increase in demand in emerging markets.
In this article: AZN, PFE, AMGN
Read
Inovio Pharmaceuticals: Partnerships Keep Rolling In
Article By: Terry Chrisomalis
Tuesday, October 21, 2014 1:32 PM EDT
Inovio Pharmaceuticals partners with MedImmune to create monoclonal antibodies against various infections.
In this article: AZN, INO, RHHBY
Read

Latest Tweets for $AZN

No tweets yet!